Corporate Universe Inc. (Pink Sheets:COUV) is pleased to announce the following corporate and operational matters to its shareholders and followers.
COUV opened its new corporate office at 3771 Nesconset Highway, South Setauket, NY, effective October 4, 2010. The new office will allow the Company to operate all of its divisions and subsidiaries in a centrally located place. Manhattan Transfer Registrar Company will continue to be located in Miller Place.
Now that the corporate changes are fully implemented, including the name change to Corporate Universe Inc., trading under the symbol (Pink Sheets:COUV), and the forward split of 10 new shares for each old share of common stock, the company is ready for business and intends to keep its followers advised on a timely basis.
COUV corporate website has officially been launched. The management will continue to update and improve it over the coming weeks.
Corporate Universe Inc., is a holding company formed in order to provide a greater range of services to the financial community. Corporate Universe’s services include, through our subsidiaries, a full service transfer agency, an EDGAR filing company, a press release company , a corporate printing company as well as a consulting group. By providing multiple services Corporate Universe can provide “one stop” service at competitive prices.
Maui Land & Pineapple Company, Inc. (NYSE:MLP) reported net income of $20.0 million, or $1.35 per share, for the third quarter of 2010, compared to a net loss of $25.5 million, or ($3.17) per share, for the third quarter of 2009. Revenues for the third quarter of 2010 were $8.2 million, compared to $20.1 million for the third quarter of 2009.
Maui Land & Pineapple Company, Inc. engages in the resort and community development businesses.
Flexsteel Industries, Inc. (NASDAQ:FLXS) recently reported net income for its first fiscal quarter ended September 30, 2010 of $2.3 million or $0.34 per share compared to a net income of $1.4 million or $0.21 per share in the prior year quarter.
Flexsteel Industries, Inc. engages in the manufacture, import, and marketing of residential, recreational vehicle, and commercial upholstered and wooden furniture products in the United States.
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) recently announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation in patients with advanced illness such as cancer.
Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States and internationally.
No comments:
Post a Comment